SARS-CoV-2 3CLpro-IN-7

Modify Date: 2024-01-22 22:38:26

Use of SARS-CoV-2 3CLpro-IN-7

SARS-CoV-2 3CLpro-IN-7 is a reversible covalent SARS-CoV-2 3CL protease inhibitor with an IC50 value of 1.4 µM[1].

Name	SARS-CoV-2 3CLpro-IN-7

Description	SARS-CoV-2 3CLpro-IN-7 is a reversible covalent SARS-CoV-2 3CL protease inhibitor with an IC50 value of 1.4 µM[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> SARS-CoV
In Vitro	SARS-CoV-2 3CLpro-IN-7 (0-100 µM; 5, 30, 60, 180 min) 以剂量和时间依赖性方式抑制 SARS-CoV-2 3CLpro 活性 [1]。
References	[1]. Wang L, et al. Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen. Eur J Med Chem. 2022 Dec 15;244:114803.

Molecular Formula	C₂₄H₁₇ClN₂O₆
Molecular Weight	464.85